1. Academic Validation
  2. Stereoselective Synthesis, Pro-resolution, and Anti-inflammatory Actions of RvD5n-3 DPA

Stereoselective Synthesis, Pro-resolution, and Anti-inflammatory Actions of RvD5n-3 DPA

  • J Nat Prod. 2023 Nov 24;86(11):2546-2553. doi: 10.1021/acs.jnatprod.3c00769.
Karina Ervik 1 Amalie F Reinertsen 1 Duco S Koenis 2 Jesmond Dalli 2 Trond V Hansen 1
Affiliations

Affiliations

  • 1 Department of Pharmacy, Section for Pharmaceutical Chemistry, University of Oslo, P.O. Box 1068, 0316 Oslo, Norway.
  • 2 Lipid Mediator Unit, Center for Biochemical Pharmacology, William Harvey Research, Institute, Barts and The London School of Medicine, Queen Mary University of London Charterhouse Square, London EC1M 6BQ, U.K.
Abstract

The methyl ester of resolvin D5n-3 DPA, a lipid mediator biosynthesized from the omega-3 fatty acid n-3 docosapentaenoic acid, was stereoselectively prepared in 8% yield over 12 steps (longest linear sequence). The key steps for the introduction of the two stereogenic secondary alcohols were an organocatalyzed oxyamination and the Midland Alpine borane reduction. For the assembly of the carbon chain, the Sonogashira cross-coupling reaction and the Takai olefination were utilized. The physical properties, including retention time in liquid chromatography and tandem mass spectra, of the synthetic material were matched against material from human peripheral blood and mouse infectious exudates. Synthetic RvD5n-3 DPA, obtained just prior to biological experiments, displayed potent leukocyte-directed activities, upregulating the ability of neutrophils and macrophages to phagocytose bacteria, known as hallmark bioactions of specialized pro-resolving endogenous mediators.

Figures
Products